Literature DB >> 32343785

Monocular Deprivation Affects Visual Cortex Plasticity Through cPKCγ-Modulated GluR1 Phosphorylation in Mice.

Yunxia Zhang1, Tao Fu2, Song Han1, Yichao Ding2, Jing Wang2, Jiayin Zheng1, Junfa Li1.   

Abstract

Purpose: To determine how visual cortex plasticity changes after monocular deprivation (MD) in mice and whether conventional protein kinase C gamma (cPKCγ) plays a role in visual cortex plasticity.
Methods: cPKCγ membrane translocation levels were quantified by using immunoblotting to explore the effects of MD on cPKCγ activation. Electrophysiology was used to record field excitatory postsynaptic potential (fEPSP) amplitude with the goal of observing changes in visual cortex plasticity after MD. Immunoblotting was also used to determine the phosphorylation levels of GluR1 at Ser831. Light transmission was analyzed using electroretinography to examine the effects of MD and cPKCγ on mouse retinal function.
Results: Membrane translocation levels of cPKCγ significantly increased in the contralateral visual cortex of MD mice compared to wild-type (WT) mice (P < 0.001). In the contralateral visual cortex, long-term potentiation (LTP) and the phosphorylation levels of GluR1 at Ser 831 were increased in cPKCγ+/+ mice after MD. Interestingly, these levels could be downregulated by cPKCγ knockout compared to cPKCγ+/++MD mice (P < 0.001). Compared to the right eyes of WT mice, the amplitudes of a-waves and b-waves declined in deprived right eyes of mice after MD (P < 0.001). There were no significant differences when comparing cPKCγ+/+ and cPKCγ-/- mice with MD. Conclusions: cPKCγ participates in the plasticity of the visual cortex after MD, which is characterized by increased LTP in the contralateral visual cortex, which may be a result of cPKCγ-mediated phosphorylation of GluR1 at Ser 831.

Entities:  

Year:  2020        PMID: 32343785     DOI: 10.1167/iovs.61.4.44

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  34 in total

Review 1.  Neurotrophic keratitis.

Authors:  S Bonini; P Rama; D Olzi; A Lambiase
Journal:  Eye (Lond)       Date:  2003-11       Impact factor: 3.775

2.  Topical treatment with nerve growth factor for corneal neurotrophic ulcers.

Authors:  A Lambiase; P Rama; S Bonini; G Caprioglio; L Aloe
Journal:  N Engl J Med       Date:  1998-04-23       Impact factor: 91.245

3.  Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1.

Authors:  S M Brown; D W Lamberts; T W Reid; T Nishida; C J Murphy
Journal:  Arch Ophthalmol       Date:  1997-07

4.  Treatment of neurotrophic keratopathy with nicergoline.

Authors:  Young-Chun Lee; Su-Young Kim
Journal:  Cornea       Date:  2015-03       Impact factor: 2.651

5.  Amniotic membrane transplantation in refractory neurotrophic corneal ulcers: a randomized, controlled clinical trial.

Authors:  Sudarshan Khokhar; Tanie Natung; Parul Sony; Namrata Sharma; Nutan Agarwal; Rasik B Vajpayee
Journal:  Cornea       Date:  2005-08       Impact factor: 2.651

6.  Ocular drug delivery systems: An overview.

Authors:  Ashaben Patel; Kishore Cholkar; Vibhuti Agrahari; Ashim K Mitra
Journal:  World J Pharmacol       Date:  2013

7.  Dendritic cell dysfunction and diabetic sensory neuropathy in the cornea.

Authors:  Nan Gao; Chenxi Yan; Patrick Lee; Haijing Sun; Fu-Shin Yu
Journal:  J Clin Invest       Date:  2016-04-11       Impact factor: 14.808

8.  Corneal neurotization: a novel solution to neurotrophic keratopathy.

Authors:  Julia K Terzis; Marylou M Dryer; Bruce I Bodner
Journal:  Plast Reconstr Surg       Date:  2009-01       Impact factor: 4.730

9.  Matrix Regeneration Therapy: A Case Series of Corneal Neurotrophic Ulcers.

Authors:  Riku P J Arvola; Alexandra Robciuc; Juha M Holopainen
Journal:  Cornea       Date:  2016-04       Impact factor: 2.651

Review 10.  Diagnosis and management of neurotrophic keratitis.

Authors:  Marta Sacchetti; Alessandro Lambiase
Journal:  Clin Ophthalmol       Date:  2014-03-19
View more
  1 in total

1.  Free Wanderer Powder regulates AMPA receptor homeostasis in chronic restraint stress-induced rat model of depression with liver-depression and spleen-deficiency syndrome.

Authors:  Shengyan Xi; Guangxin Yue; Yueyun Liu; Yanan Wang; Yingkun Qiu; Zhigeng Li; Pei Ma; Tiegang Liu; Youming Jiang; Yuan Liang; Qun Liu; Jing Shi; Jiaxu Chen; Lifeng Yue
Journal:  Aging (Albany NY)       Date:  2020-10-14       Impact factor: 5.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.